Denns Ledford, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Genentech
    Topic:
    Urticaria
    Date added:
    03/14/2026
    Date updated:
    03/14/2026
    Relationship end date:
    12/31/2025
  • Attribution:
    Self
    Type of financial relationship:
    Consultant
    Ineligible company:
    Novartis
    Topic:
    Urticaria
    Date added:
    03/14/2026
    Date updated:
    03/14/2026
    Relationship end date:
    12/31/2026
  • Attribution:
    Self
    Type of financial relationship:
    Researcher
    Ineligible company:
    AstraZeneca
    Topic:
    Asthma
    Date added:
    03/14/2026
    Date updated:
    03/14/2026
    Relationship end date:
    12/31/2025
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor (including contracted research)
    Ineligible company:
    AstraZeneca
    Topic:
    Asthma, vasculitis, CRSwNP, type 2 inflammation
    Date added:
    03/14/2026
    Date updated:
    03/14/2026
    Relationship end date:
    12/31/2026
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor (including contracted research)
    Ineligible company:
    Novartis
    Topic:
    Urticaria
    Date added:
    03/14/2026
    Date updated:
    03/14/2026
    Relationship end date:
    12/31/2026
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor (including contracted research)
    Ineligible company:
    Sanofi
    Topic:
    Urticaria, asthma, COPD, CRSwNP, atopic dermatitis, prurigo nodularis, bullous pemphigoid
    Date added:
    03/14/2026
    Date updated:
    03/14/2026
    Relationship end date:
    12/31/2026
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor (including contracted research)
    Ineligible company:
    GSK
    Topic:
    asthma, vasculitis
    Date added:
    03/14/2026
    Date updated:
    03/14/2026
    Relationship end date:
    12/31/2026
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor (including contracted research)
    Ineligible company:
    Regeneron
    Topic:
    Asthma,COPD, urticaria, atopic dermatitis, CRSwNP, bullous pemphigoid, prurigo nodularis
    Date added:
    03/14/2026
    Date updated:
    03/14/2026
    Relationship end date:
    12/31/2026
Return to FAAIS 2026 Annual Meeting